Inventor
KANG JASPAL SINGH
CA26 patents
⚠️ This page may combine multiple inventors who share the name “KANG JASPAL SINGH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIMMUNE LTD
5 patentsUS9493565B2Nov 15, 2016
Targeted binding agents against B7-H1
MEDIMMUNE LTD50 citations95
US10400039B2Sep 3, 2019
Targeted binding agents against B7-H1
MEDIMMUNE LTD8 citations82
US8858942B2Oct 14, 2014
Antibodies directed to ERBB2
MEDIMMUNE LTD11 citations80
US8350011B2Jan 8, 2013
Antibodies to ErbB2
MEDIMMUNE LTD10 citations80
US11518809B2Dec 6, 2022
Targeted binding agents against B7-H1
MEDIMMUNE LTD0 citations60
INNOVATIVE TARGETING SOLUTIONS INC
5 patentsUS8012714B2Sep 6, 2011
Sequence diversity generation in immunoglobulins
INNOVATIVE TARGETING SOLUTIONS INC17 citations90
US9718871B2Aug 1, 2017
Generating targeted sequence diversity in proteins
INNOVATIVE TARGETING SOLUTIONS INC2 citations66
US10233453B2Mar 19, 2019
Generating targeted sequence diversity in fusion proteins
INNOVATIVE TARGETING SOLUTIONS INC1 citations60
US10563206B2Feb 18, 2020
Generating targeted sequence diversity in fusion proteins
INNOVATIVE TARGETING SOLUTIONS INC0 citations50
US9914929B2Mar 13, 2018
Generating targeted sequence diversity in fusion proteins
INNOVATIVE TARGETING SOLUTIONS INC0 citations50
AMGEN FREMONT INC
5 patentsUS7572444B2Aug 11, 2009
Binding proteins specific for human matriptase
AMGEN FREMONT INC12 citations77
US10508153B2Dec 17, 2019
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC1 citations72
US7771951B2Aug 10, 2010
Antibody categorization based on binding characteristics
AMGEN FREMONT INC5 citations71
US7754433B2Jul 13, 2010
Identification of high affinity molecules by limited dilution screening
AMGEN FREMONT INC3 citations62
US11492411B2Nov 8, 2022
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC0 citations61